These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30430423)

  • 1. Promoter Mutation Analysis of ALDOA Gene in Solid Tumors and Acute Leukemias.
    Son HJ; Choi EJ; Yoo NJ; Lee SH
    Pathol Oncol Res; 2019 Apr; 25(2):825-826. PubMed ID: 30430423
    [No Abstract]   [Full Text] [Related]  

  • 2. [LRP15 gene promoter region methylation and its expression in acute leukemia].
    Zhao Y; Dou LP; Wang QS; Lu XC; Lou FD; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):39-41. PubMed ID: 17490517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute leukemias in children with Down syndrome.
    Zwaan CM; Reinhardt D; Hitzler J; Vyas P
    Hematol Oncol Clin North Am; 2010 Feb; 24(1):19-34. PubMed ID: 20113894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression profiles of human leukemias.
    Takada S; Yamashita Y; Berezikov E; Hatanaka H; Fujiwara SI; Kurashina K; Watanabe H; Enomoto M; Soda M; Choi YL; Mano H
    Leukemia; 2008 Jun; 22(6):1274-8. PubMed ID: 17989710
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of recurrent cytogenetic abnormalities in acute lymphoblastic and myeloid leukemias using fluorescence in situ hybridization.
    Vance GH
    Methods Mol Biol; 2013; 999():79-91. PubMed ID: 23666691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of NOTCH1 extracellular juxtamembrane expansion mutations in acute leukemias and multiple myelomas.
    Kim YR; Eom HS; Min CK; Lee S; Chung NG; Yoo NJ; Lee SH
    APMIS; 2009 Feb; 117(2):147-8. PubMed ID: 19239437
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic Testing in the Diagnosis and Biology of Acute Leukemia.
    Harris MH; Czuchlewski DR; Arber DA; Czader M
    Am J Clin Pathol; 2019 Aug; 152(3):322-346. PubMed ID: 31367767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of KIR2DS4 and its variant KIR1D with leukemia.
    Giebel S; Nowak I; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Kyrcz-Krzemien S; Kusnierczyk P
    Leukemia; 2008 Nov; 22(11):2129-30; discussion 2130-1. PubMed ID: 18463675
    [No Abstract]   [Full Text] [Related]  

  • 9. Oncogenic ERBB3 mutations altering p.Val104 is rare in acute leukemias and non-Hodgkin lymphomas.
    Choi MR; Yoo NJ; Lee SH
    Eur J Haematol; 2014 Feb; 92(2):177-8. PubMed ID: 24138610
    [No Abstract]   [Full Text] [Related]  

  • 10. Leukemias of indeterminant lineage.
    Lee EJ; Schiffer CA
    Clin Lab Med; 1990 Dec; 10(4):737-54. PubMed ID: 2272172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of p300 gene promoter methylation in acute leukemia.
    Chim CS; Wong AS; Kwong YL
    Cancer Genet Cytogenet; 2004 Apr; 150(2):164-7. PubMed ID: 15066326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of hypermethylation of p15 gene in patients with acute leukemia by polymerase chain reaction].
    Chen F; Zeng X
    Zhonghua Xue Ye Xue Za Zhi; 2000 May; 21(5):250-2. PubMed ID: 11876990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute leukemia: a pediatric perspective.
    Downing JR; Shannon KM
    Cancer Cell; 2002 Dec; 2(6):437-45. PubMed ID: 12498712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutically Targetable ALK Mutations in Leukemia.
    Maxson JE; Davare MA; Luty SB; Eide CA; Chang BH; Loriaux MM; Tognon CE; Bottomly D; Wilmot B; McWeeney SK; Druker BJ; Tyner JW
    Cancer Res; 2015 Jun; 75(11):2146-50. PubMed ID: 26032424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In acute leukemia, the polymorphism -211C>T in the promoter region of the multidrug resistance-associated protein 3 (MRP3) does not determine the expression level of the gene.
    Doerfel C; Rump A; Sauerbrey A; Gruhn B; Zintl F; Steinbach D
    Pharmacogenet Genomics; 2006 Feb; 16(2):149-50. PubMed ID: 16424827
    [No Abstract]   [Full Text] [Related]  

  • 16. Clonal development and cytogenetics of acute leukaemias.
    Najfeld V
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():12. PubMed ID: 2627599
    [No Abstract]   [Full Text] [Related]  

  • 17. [The significance of DNA-binding inhibitor 4 promoter methylation status in acute leukemia].
    Zhao Y; Yu L; Wang QS; Li HH; Bo J; Dou LP
    Zhonghua Nei Ke Za Zhi; 2006 Jul; 45(7):576-8. PubMed ID: 17074115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinase domain mutation of ERBB family genes is uncommon in acute leukemias.
    Lee JW; Soung YH; Kim SY; Nam SW; Park WS; Lee JY; Yoo NJ; Lee SH
    Leuk Res; 2006 Feb; 30(2):241-2. PubMed ID: 16054688
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence-based RT-PCR methods for the detection of the 8 most common MLL aberrations in acute leukemias.
    Burmeister T; Meyer C; Gröger D; Hofmann J; Marschalek R
    Leuk Res; 2015 Feb; 39(2):242-7. PubMed ID: 25510485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathology.
    Duque RE; Andreeff M; Braylan RC; Diamond LW; Peiper SC
    Cytometry; 1993; 14(5):492-6. PubMed ID: 8354121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.